Skip to content

MENU

Read and Search Our Blog PostsWhat We DoCheck Out Our Law FirmGet In Touch With Us
STARK & STARK logo

Mass Torts Law Blog

Actonel

Subscribe to Actonel

What are bisphosphonates?

By Martin P. Schrama on April 27, 2009
Posted in Actonel, Aredia, Defective Drugs, Fosamax, Zometa

Bisphosphonates are a class of drugs that drug companies claim promote bone regeneration. Bisphosphonates are commonly sold under various brand names including Fosamax®, Actonel®, Aredia® and Zometa®.
…
Continue Reading What are bisphosphonates?

Stay Connected

Subscribe to this blog via RSS Find Us on Facebook View My Linkedin Profile Follow Us on Twitter Find us on YouTube

Authors Show/Hide

  • Craig S. Hilliard
  • Kevin M. Hart
  • Martin P. Schrama
  • Stefanie Colella-Walsh

Topics

Archives

Contact Us

Stark & Stark Network

  • Construction Litigation Law Blog
  • New Jersey Law Blog
  • Nursing Home Law Blog
  • Pennsylvania Law Monitor
  • Personal Injury Law Journal
  • Traumatic Brain Injury Law Blog
  • Truck & Bus Accident Lawyer Blog

Recent Updates

  • A Simple Guide to Exactech Hip, Knee and Ankle Replacement Lawsuits and Settlements
  • A Definitive Guide to ParaGard Lawsuits
  • Most Vaccine Injuries Are Covered by the VICP – Except for the COVID Shots That We All Just Received
  • A Simple Guide to CPAP Lawsuits and Settlements
  • How Do I Know If I Have A Singulair Lawsuit Claim

Mass Torts Law Blog

STARK & STARK logo
Princeton  | 
Marlton  | 
New York  | 
Philadelphia  | 
Yardley  | 
Subscribe to this blog via RSS Find Us on Facebook View My Linkedin Profile Follow Us on Twitter Find us on YouTube
DisclaimerPrivacy Policy

About Us

The attorneys of Stark & Stark’s Mass Tort team work tirelessly on behalf of their clients to obtain maximum compensation for their injuries. The Mass Tort group prosecutes individual claims for personal injury which arise out of a common set of facts or circumstances, such as the use of a defective drug or a catastrophic event which causes common injuries.

Read More...
Copyright © 2023, STARK & STARK. ATTORNEY ADVERTISING
Law blog design & platform by LexBlog LexBlog Logo